» Articles » PMID: 35388695

Peptide Permeation Across a Phosphocholine Membrane: An Atomically Detailed Mechanism Determined Through Simulations and Supported by Experimentation

Overview
Journal J Phys Chem B
Specialty Chemistry
Date 2022 Apr 7
PMID 35388695
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-penetrating peptides (CPPs) facilitate translocation across biological membranes and are of significant biological and medical interest. Several CPPs can permeate into specific cells and organelles. We examine the incorporation and translocation of a novel anticancer CPP in a dioleoylphosphatidylcholine (DOPC) lipid bilayer membrane. The peptide, NAF-1, is a short fragment of a transmembrane protein, consisting of hydrophobic N-terminal and charged C-terminal segments. Experiments using fluorescently labeled NAF-1 in ∼100 nm DOPC vesicles and atomically detailed simulations conducted with Milestoning support a model in which a significant barrier for peptide-membrane entry is found at the interface between the aqueous solution and membrane. The initial step is the insertion of the N-terminal segment and the hydrophobic helix into the membrane, passing the hydrophilic head groups. Both experiments and simulations suggest that the free energy difference in the first step of the permeation mechanism in which the hydrophobic helix crosses the phospholipid head groups is -0.4 kcal mol slightly favoring motion into the membrane. Milestoning calculations of the mean first passage time and the committor function underscore the existence of an early polar barrier followed by a diffusive barrierless motion in the lipid tail region. Permeation events are coupled to membrane fluctuations that are examined in detail. Our study opens the way to investigate in atomistic resolution the molecular mechanism, kinetics, and thermodynamics of CPP permeation to diverse membranes.

Citing Articles

Optimizing properties of translocation-enhancing transmembrane proteins.

Bartos L, Drabinova M, Vacha R Biophys J. 2024; 123(10):1240-1252.

PMID: 38615194 PMC: 11140465. DOI: 10.1016/j.bpj.2024.04.009.


Peptide translocation across asymmetric phospholipid membranes.

Bartos L, Vacha R Biophys J. 2024; 123(6):693-702.

PMID: 38356262 PMC: 10995401. DOI: 10.1016/j.bpj.2024.02.006.


A combination of a cell penetrating peptide and a protein translation inhibitor kills metastatic breast cancer cells.

Rowland L, Marjault H, Karmi O, Grant D, Webb L, Friedler A Cell Death Discov. 2023; 9(1):325.

PMID: 37652915 PMC: 10471752. DOI: 10.1038/s41420-023-01627-3.


A molecular dynamics study of cell-penetrating peptide transportan-10 (TP10): Binding, folding and insertion to transmembrane state in zwitterionic membrane.

Bennett A, Cranford K, Bates A, Sabatini C, Lee H Biochim Biophys Acta Biomembr. 2023; 1866(1):184218.

PMID: 37634858 PMC: 10843101. DOI: 10.1016/j.bbamem.2023.184218.


Leaflet-Dependent Effect of Anionic Lipids on Membrane Insertion by Cationic Cell-Penetrating Peptides.

Povilaitis S, Webb L J Phys Chem Lett. 2023; 14(25):5841-5849.

PMID: 37339513 PMC: 10478718. DOI: 10.1021/acs.jpclett.3c00725.


References
1.
Ma P, Cardenas A, Chaudhari M, Elber R, Rempe S . The Impact of Protonation on Early Translocation of Anthrax Lethal Factor: Kinetics from Molecular Dynamics Simulations and Milestoning Theory. J Am Chem Soc. 2017; 139(42):14837-14840. PMC: 5656527. DOI: 10.1021/jacs.7b07419. View

2.
Kim G, Cheon D, Lee Y . Challenge to overcome current limitations of cell-penetrating peptides. Biochim Biophys Acta Proteins Proteom. 2021; 1869(4):140604. DOI: 10.1016/j.bbapap.2021.140604. View

3.
Cardenas A, Shrestha R, Webb L, Elber R . Membrane permeation of a peptide: it is better to be positive. J Phys Chem B. 2015; 119(21):6412-20. PMC: 4503241. DOI: 10.1021/acs.jpcb.5b02122. View

4.
Vanden-Eijnden E, Venturoli M . Markovian milestoning with Voronoi tessellations. J Chem Phys. 2009; 130(19):194101. DOI: 10.1063/1.3129843. View

5.
Desale K, Kuche K, Jain S . Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics. Biomater Sci. 2020; 9(4):1153-1188. DOI: 10.1039/d0bm01755h. View